Robert Coffin Ph.D.
Net Worth
Last updated:
What is Robert Coffin Ph.D. net worth?
The estimated net worth of Dr. Robert Coffin Ph.D. is at least $23,248,733 as of 16 May 2024. He owns shares worth $9,583,047 as insider, has earned $9,108,566 from insider trading and has received compensation worth at least $4,557,120 in Replimune Group, Inc..
What is the salary of Robert Coffin Ph.D.?
Dr. Robert Coffin Ph.D. salary is $759,520 per year as Founder, Pres, Chief R&D Officer and Director in Replimune Group, Inc..
How old is Robert Coffin Ph.D.?
Dr. Robert Coffin Ph.D. is 60 years old, born in 1965.
What stocks does Robert Coffin Ph.D. currently own?
As insider, Dr. Robert Coffin Ph.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Replimune Group, Inc. (REPL) | Founder, Pres, Chief R&D Officer and Director | 1,821,872 | $5.26 | $9,583,047 |
What does Replimune Group, Inc. do?
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes simplex virus 1, which is in Phase I/II clinical trials for a range of solid tumors; and that is in Phase II clinical trials for patients with cutaneous squamous cell carcinoma. It is also developing RP2, which is in Phase I clinical trials for an anti-CTLA-4 antibody-like protein in order to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3 that is in Phase I clinical trials to express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.
Robert Coffin Ph.D. insider trading
Replimune Group, Inc.
Dr. Robert Coffin Ph.D. has made 15 insider trades between 2019-2024, according to the Form 4 filled with the SEC. Most recently he sold 11,464 units of REPL stock worth $74,172 on 16 May 2024.
The largest trade he's ever made was exercising 220,000 units of REPL stock on 22 Dec 2020. As of 16 May 2024 he still owns at least 1,821,872 units of REPL stock.
Replimune Group key executives
Replimune Group, Inc. executives and other stock owners filed with the SEC:
- Dr. Robert Coffin Ph.D. (60) Founder, Pres, Chief R&D Officer and Director
- Mr. Philip Astley-Sparke FSA (54) Chief Executive Officer & Director
- Ms. Tanya N. Lewis M.S. (54) Chief Devel. Operations Officer